Jeffrey Millard

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Insulin Resistance

Pulmonary Artery

Clinical Evaluation

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)
D Lynn Kirkpatrick, Cari Evans, Linda A Pestano, Jeffrey Millard, Matthew Johnston, Emily Mick, William K Schmidt
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers. Clinical and translational science 17 (3) (2024)